Tag: Tricyclic antidepressant / H1 antagonist

  • Doxepin (Low-Dose)

    Tricyclic antidepressant / H1 antagonist

    Abstract

    At low doses, the compound shows selective H1 antihistamine activity; muscarinic, alpha-1 adrenergic, and serotonergic activities relevant at higher antidepressant doses are minimal. The H1-mediated sleep maintenance effect targets sleep continuity rather than sleep onset. Pharmacokinetics: plasma half-life 15 hours; CYP2D6 and CYP1A2 metabolism. Schedule status: prescription-only; not federally scheduled.

    FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human or animal consumption. All information is provided for research and educational purposes only.